Mucolipidosis IV: Novel Mutation and Diverse Ultrastructural Spectrum in the Skin

Abstract

Mucolipidosis IV, a severe neurologic and ophthalmologic progressive disorder has a clinical range of onset between early childhood and adolescence entailing clinically severe, moderate, and mild forms, all of them majorly affecting Ashkenazi Jewish patients in an autosomal-recessive fashion owing to mutations in the MCOLN1 gene which encodes a transmembrane protein called mucolipin 1. We report on one of two affected siblings, the older brother having died of ML IV at the age of 33 years, the younger recently at the age of 37 years. Biopsied skin disclosed several types of lysosomal residual bodies, membrane-bound vacuoles, avacuolar lamellar bodies resembling membraneous cytoplasmic bodies, and a diverse spectrum of lipopigments which include curvilinear and fingerprint profiles. Contrary to earlier reports, disease-specific lysosomal residual bodies could not be identified in circulating lymphocytes of our patient. Mutation analysis revealed a homozygous novel mutation of a 34 bp deletion and 3 bp insertion in exon 2 of the MCOLN1 gene, perhaps the reason for this unusual clinical and morphological phenotype.

Key words

Mucolipidosis IV - MCOLN1 Mutation - Ultrastructure - Skin - Protracted Form

References

• 1 Acierno J S, Kennedy J C, Falardeau J L, Leyne M, Bromley M C, Colman M W. et al . A physical and transcript map of the MCOLN1 gene region on human chromosome 19 p13. 3-p13. 2.  Genomics. 2001;  73 203-210
• 2 Amir N, Zlotogora J, Bach G. Mucolipidosis type IV: clinical spectrum and natural history.  Pediatrics. 1987;  79 953-959
• 3 Bach G. Mucolipidosis type IV: A review.  Mol Genet Metab. 2001;  73 197-203
• 4 Bargal R, Avidan N, Ben-Asher E, Olender Z, Zeigler M, Frumkin A. et al . Identification of the gene causing mucolipidosis type IV [letter].  Nat Genet. 2000;  26 118-121
• 5 Bargal R, Avidan N, Olender Z, Ben-Asher E, Zeigler M, Raas-Rothschild A. et al . Mucolipidosis type IV: Novel mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population.  Hum Mutat. 2001;  17 397-402
• 6 Bassi M T, Manzoni M, Monti E, Pizzo M T, Ballabio A, Borsani G. Cloning of the gene encoding a novel integral membrane protein, mucolipin - and identification of the two major founder mutations causing mucolipidosis type IV.  Am J Hum Genet. 2000;  67 1110-1120
• 7 Berman E R, Livni N, Shapira E, Merin S, Levij I S. Congenital corneal clouding with abnormal systemic storage bodies: a new variant of mucolipidosis.  J Pediatr. 1974;  34 519-526
• 8 Caimi L, Tettamanti G, Berra B, Omodeo Sale F, Borrone C, Gatti R. et al . Mucolipidosis IV, a sialolipidosis due to ganglioside sialidase deficiency.  J Inherit Metab Dis. 1982;  5 218-224
• 9 Chen C-S, Bach G, Pagno R. Abnormal transport along the lysosomal pathway in mucolipidosis type IV disease.  Proc Natl Acad Sci USA. 1998;  95 6373-6378
• 10 Chitayat D, Meunier C M, Hodgkinson K A, Silver K, Flanders M, Anderson I J. et al . Mucolipidosis type IV: clinical manifestations and natural history.  Am J Med Genet. 1991;  41 313-318
• 11 Crandall B F, Philippart M, Brown W J, Bluestone D A. Review article: mucolipidosis IV.  Am J Med Genet. 1982;  12 301-308
• 12 Folkerth R D, Alroy J, Lomakina I, Skutelsky E, Raghavan S S, Kolodny E H. Mucolipidosis IV: morphology and histochemistry of an autopsy case.  J Neuropathol Exp Neurol. 1995;  54 154-164
• 13 Goebel H H, Kohlschütter A, Lenard H G. Morphologic and chemical biopsy findings in mucolipidosis IV.  Clin Neuropathol. 1982;  1 73-82
• 14 Goebel H H. The new nosography of the neuronal ceroid-lipofuscinoses.  Ann Pathol. 2000;  20 479-491
• 15 Goebel H H, Latta E, Bach G. Protracted type of mucolipidosis (ML) IV.  J Neuropathol Exp Neurol. 2001;  60 557
• 16 Goldin E, Blanchette-Mackie E J, Dwyer N K, Pentchev P G, Brady R O. Cultured skin fibroblasts derived from patients with mucolipidosis 4 are autofluorescent.  Pediatr Res. 1995;  37 687-692
• 17 Goldin E, Cooney A, Kaneski C R, Brady R O, Schiffmann R. Mucolipidosis IV consists of one complementation group.  Proc Natl Acad Sci USA. 1999;  96 8562-8566
• 18 Kohn G, Livni N, Beyth Y. Prenatal diagnosis of mucolipidosis IV by electron microscopy.  Pediatr Res. 1975;  9 314
• 19 Latta E, Fuhrmann-Rieger A. Ungeklärter metabolischer Schwachsinn mit multiplen Stigmata und Hornhauttrübung bei zwei Brüdern. Spranger J, Tolksdorf M Klinische Genetik in der Pädiatrie. Stuttgart; Georg Thieme Verlag 1980: 144-147
• 20 Livni N, Merin S. Mucolipidosis IV.  Arch Pathol Lab Med. 1978;  102 600-604
• 21 Lowden J A, Callahan J W, Gravel R A, Skomorowski M A, Becker L, Groves J. Type 2 GM₁ gangliosidosis with long survival and neuronal ceroid-lipofuscinosis.  Neurology. 1981;  31 719-724
• 22 Ornoy A, Arnon J, Grebner E E, Jackson L G, Bach G. Letter to the editor: Early prenatal diagnosis of mucolipidosis IV.  Am J Med Genet. 1987;  27 983-985
• 23 Reis S, Sheffer R N, Merin S, Luder A S, Bach G. Mucolipidosis type IV: a mild form with late onset.  Am J Med Genet. 1993;  47 392-394
• 24 Sekeles E, Ornoy A, Cohen R, Kohn G. Mucolipidosis IV: fetal and placental pathology.  Monogr Hum Genet. 1978;  10 47-50
• 25 Slaugenhaupt S A, Acierno S SJ, Helbling L A, Bove C, Goldin E, Bach G. et al . Mapping of the mucolipidosis type IV gene to chromosome 19 p and definition of founder haplotypes.  Am J Hum Genet. 1999;  65 773-778
• 26 Sun M, Goldin E, Stahl S, Falardeau J L, Kennedy J C, Acierno J S. et al . Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel.  Hum Mol Genet. 2000;  9 2471-2478
• 27 Tellez-Nagel I, Rapin I, Iwamoto T, Johnson A B, Norton W T, Nitowsky H. Mucolipidosis IV.  Arch Neurol. 1976;  33 828-835
• 28 Wisniewski K E, Rudelli R, Laure-Kaminonowska M, Sklower S, Houck G E, Kieras F. et al . Sanfilippo disease, type A with some features of ceroid-lipofuscinosis.  Neuropediatrics. 1985;  16 98-105